OpenVSafe by OpenVAERS
Search V-safe

BXF-25591-13866

3 vaccinations 11 coded responses 33 check-ins 11 free-text entries 0 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
924 / CA
Registered
2021-06-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-01
    Registered in v-safe
  2. 2021-06-01
    Dose 1 — Pfizer-BioNTech
  3. 2021-06-01
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-06-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea — Feeling: Fair · Muscle or body aches
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-06-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-06-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-06-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  8. 2021-06-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-06-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2021-06-08
    Survey response — day 7, dose 1
    MedDRA: Depression — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Increase in depression
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-06-15
    Survey response — day 14, dose 1
    MedDRA: Fatigue — Feeling: Fair
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-06-22
    Dose 2 — Pfizer-BioNTech
  13. 2021-06-22
    Health check-in — day 0, dose 2
    Feeling: Fair · None
    Adult check-in
  14. 2021-06-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Swelling · Muscle or body aches
    Adult check-in
  15. 2021-06-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety, Depression — Feeling: Fair · Site: Redness, Swelling · Fatigue or tiredness
    Free text: Increase in depression and anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-06-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  17. 2021-06-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety, Condition aggravated, Depression, Pre-existing disease — Feeling: Poor · Site: Swelling
    Free text: Severe depression and anxiety; increase in problems with memory (hemorrhagic stroke in 05/2019)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-06-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety, Depression, Memory impairment, Pre-existing disease — Feeling: Poor · Site: Swelling · Fatigue or tiredness
    Free text: Severe depression and anxiety; increase in memory problems (previous hemorrhagic stroke 05/19)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-06-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anxiety, Condition aggravated, Depression, Pre-existing disease — Feeling: Poor · Fatigue or tiredness
    Free text: Severe depression/anxiety; increase in memory problems (05/2019 hemorrhagic stroke)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-06-29
    Survey response — day 7, dose 2
    MedDRA: Anxiety, Depression — Feeling: Fair · Site: Swelling
    Free text: Increase in depression/anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-07-06
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-07-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-21
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-07-28
    Survey response — day 35, dose 2
    MedDRA: Anxiety, Depression — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Severe depression and anxiety.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-08-03
    Survey response — day 42, dose 2
    MedDRA: Fatigue — Feeling: Fair
    Free text: Fatigue
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-09-23
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  27. 2021-12-22
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  28. 2022-02-01
    Dose 3 — Pfizer-BioNTech
  29. 2022-02-09
    Health check-in — day 7, dose 3
    Feeling: Fair · Site: Itching · None
    Adult check-in
  30. 2022-02-15
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  31. 2022-02-23
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  32. 2022-03-01
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  33. 2022-03-08
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  34. 2022-03-15
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-05-05
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-08-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2023-02-03
    Health check-in — 12 months, dose 3
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-06-01Pfizer-BioNTech
22021-06-22Pfizer-BioNTech No
32022-02-01Pfizer-BioNTech No

Free text

Release 8 — days 1–6 daily, dose 1

2021-06-02

Systemic reaction (other): Runny nose

2021-06-04

Systemic reaction (other): Dizziness

Release 8 — day 7, dose 1

2021-06-08

Systemic reaction (other): Increase in depression

Release 9 — day 14, dose 1

2021-06-15

Symptoms: Fatigue

Release 9 — days 1–6 daily, dose 2

2021-06-24

Systemic reaction (other): Increase in depression and anxiety

2021-06-26

Systemic reaction (other): Severe depression and anxiety; increase in problems with memory (hemorrhagic stroke in 05/2019)

2021-06-27

Systemic reaction (other): Severe depression and anxiety; increase in memory problems (previous hemorrhagic stroke 05/19)

2021-06-28

Systemic reaction (other): Severe depression/anxiety; increase in memory problems (05/2019 hemorrhagic stroke)

Release 9 — day 7, dose 2

2021-06-29

Systemic reaction (other): Increase in depression/anxiety

Release 9 — day 35, dose 2

2021-07-28

Symptoms: Severe depression and anxiety.

Release 9 — day 42, dose 2

2021-08-03

Symptoms: Fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ · ✓
SDDepression ✓ · ✓
SDFatigue ✓ ✓ ✓
SROAnxiety ✓ ✓ ✓
SROCondition aggravated ✓ ✓ ✓
SRODepression ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROMemory impairment ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release